660P - Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies

Autor: Klempner, S.J., Bendell, J., Meucci Villaflor, V., Tenner, L., Stein, S., Sirard, C.A., Newman, W., Kagey, M., Schlienger, K., Strickler, J.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect